Sankala Group’s Zimmer Biomet ZBH Stock Holding History

Sankala Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.94K	Hold	40	–	–	﹤0.01%	447
2025 Q4	$3.94K	Buy	+40	New	+$3.79K	﹤0.01%	465

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sankala Group's ZBH Position: Q1 2026 in Review

Sankala Group held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 40 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Sankala Group first reported a position in ZBH in Q4 2025 and has held it in 2 quarters since. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Sankala Group held 40 shares of Zimmer Biomet worth $3.94K as of Q1 2026.
Sankala Group left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #447 holding.
Sankala Group first reported a position in Zimmer Biomet in Q4 2025 and has held it in 2 quarters since.
914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.